Rachna Shroff, MD, MS, FASCO
@rachnatshroff
Followers
5K
Following
14K
Media
621
Statuses
4K
GI Oncologist, focus pancreatic, biliary cancers, personalized tx’s. Love to dance, travel, and spend time with my family. ASCO FCOI: https://t.co/oXHqwATEeE
University of Arizona
Joined October 2012
Thank you @HodaAndJenna for raising awareness for #PancreaticCancer - was a privilege to demystify this disease! Plus, since @mindykaling was featured too, I feel like we are now buddies #desisisters! @UAZCancer @UAZHealth @UAWomenAcadMed @HemOncWomenDocs
today.com
Nurses Mike and Missy Skaggs share their battle against pancreatic cancer after Mike was diagnosed with the disease at 47. Mike’s doctor, Dr. Christopher Sonnenday, also discusses the difficulty with...
5
10
81
Silver Darmer gained years with family thanks to a clinical trial at the @UAZCancer. Combining immunotherapy with targeted chemotherapy offers new hope for patients with metastatic pancreatic cancer. More: https://t.co/bwZ7nafQke
@UAZMedTucson @BannerHealth
0
4
4
~2 wks to #ESMO25! Here’s a📝of🔑studies for GeneralOnc that could change/reinforce SoC: - #DESTINYBreast 05&11 - #monarchE & #NATALEE - #VIKTORIA1 - #FORTITUDE01 - #DYNAMIC3 - #STELLAR303 - #KN905 - #IMVigor011 - #PSMAddition - #MDTBridge
#OncTwitter @myESMO @OncoAlert
2
69
193
Kicking off the 7th Annual #Cholangiocarcinoma Summit in Scottsdale, AZ. 🌵 Together, we’re building knowledge, community, and hope.
0
7
25
Heavy lifting by @Val_LeBleu @drsmags @DrShubhamPant @EJShpallMD @Aiims1742 @rkalluriMDPhD @krishnaniyer199 @mcandrews_kate @loukirtley @cara_haymaker @MikeGagea @abhinavjain_phd @rachnatshroff and other co-authors not online 🤩
1
2
8
🎉 It’s Official! Our phase 1️⃣ trial of iExosomes in metastatic pancreatic cancer is now published in @NatureComms Zero DLTs in this first-in-human trial of systemically administered engineered exosomes targeting KRAS G12D ‼️ Phase 2️⃣ is underway! https://t.co/6AdEqYLRJ0
nature.com
Nature Communications - iExoKrasG12D are engineered exosomes for the delivery of siRNA targeting KRASG12D. Here the authors describe the results of a phase I trial of iExoKrasG12D in patients with...
4
13
36
Empowering Women Leaders in Oncology at LEAD 2025 - Rachna Shroff @rachnatshroff
https://t.co/cgrVY1XgJL
#OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #LEAD25
0
1
6
Welcome to LEAD2025! Co-chairs @JulieBrahmer @KatieLaiMD_MPH @AnaVManana @rachnatshroff kick off this year’s LEAD conference with opening remarks & conference overview including Women Leaders in Oncology (WLO) Fundraising. Donate here: https://t.co/Uj0UdL209b
@WeAreWLO
0
2
4
Starting #LEAD2025 with an outstanding professional vignette panel with women leaders in #oncology across academia, industry, and community practice @RodriguezGIMD @HornLeora @JenniferGrandis
@BioAscend @HemOncWomenDocs
1
11
34
👉 “To serve our patients best, every patient should be getting comprehensive molecular profiling." 📰 Hear from experts including @rachnatshroff on the advancing field of precision medicine in #biliary tract cancer, including approvals and challenges: https://t.co/Cjr55FFxlE
gioncologynow.com
Advances in targeted, immune therapies are reshaping BTC care, but molecular testing and new trials remain vital.
0
1
2
So honored to be on this list of incredible powerhouse women! Thank you @oncodaily! @UAZCancer @UAZMedTucson @UAZHealth @UAZHemeOnc
𝟏𝟎𝟎 𝐈𝐧𝐟𝐥𝐮𝐞𝐧𝐭𝐢𝐚𝐥 𝐖𝐨𝐦𝐞𝐧 𝐢𝐧 𝐎𝐧𝐜𝐨𝐥𝐨𝐠𝐲: 𝐊𝐞𝐲 𝐎𝐩𝐢𝐧𝐢𝐨𝐧 𝐋𝐞𝐚𝐝𝐞𝐫𝐬 𝐭𝐨 𝐅𝐨𝐥𝐥𝐨𝐰 𝐨𝐧 𝐒𝐨𝐜𝐢𝐚𝐥 𝐌𝐞𝐝𝐢𝐚 𝐢𝐧 𝟐𝟎𝟐𝟓 Last week, on August 26th, in honor of Women’s Equality Day in the United States, commemorating the 1920 law granting
1
2
12
Hear @DrShubhamPant and @rachnatshroff discuss how KRAS mutations, long considered “undruggable” in pancreatic cancer, are now emerging as actionable targets, offering new hope for a historically treatment-resistant disease. Watch more here!
onclive.com
Panelists discuss how KRAS mutations, long considered “undruggable” in pancreatic cancer, are now emerging as actionable targets thanks to allele-specific inhibitors, marking a turning point in...
0
3
6
"Any patient who's a candidate for perioperative chemotherapy is a candidate for the addition of durvalumab." —Dr. Syma Iqbal, @KeckMedicineUSC @uscnorris MORE HERE:👉 https://t.co/fBpj0FuAKR ✅12-20% HER2+ patients: T-DXd boosts survival to ✅14.7 vs 11.4 mo (HR 0.70, p=0.04)!
8
3
7
Wonderful #HPB symposium hosted by @UAZCancer @UAZMedTucson @BannerUnivMed! Great discussions, wonderful colleagues! @TaylorRiall @FlavioRochaMD @drjunaidarsh @ajscott40 @carrieluumd @FaisalShahJehan @ZhiVenFongMD
1
5
19
Great discussion/cases in the Sonoran 🏜️ Academic surgery is a 🎁 @UofAZSurgery @OHSUKnight
Keynote speaker @FlavioRochaMD . Comprehensive talk Summarizing Rx options for CRLM. We have come a long way and haveway more options #HAI #transplant #liverdirectedtherapy
@UofAZSurgery 2nd annual U o A HPB symposium.
0
5
28
Keynote speaker @FlavioRochaMD . Comprehensive talk Summarizing Rx options for CRLM. We have come a long way and haveway more options #HAI #transplant #liverdirectedtherapy
@UofAZSurgery 2nd annual U o A HPB symposium.
0
4
30
At @UofAZSurgery for 2nd Annual #HPB Course Looking 👀 forward to a comprehensive program Thx 🙏🏼 @TaylorRiall and @rachnatshroff for ✉️
2
4
17
🔥 Congratulations @rachnatshroff on receiving the WIMS Torchbearer Award 🌟 A nationally renowned leader in GI oncology, clinical trials, and mentorship, she continues to light the way for women in medicine and oncology @UAZHemeOnc @UAZCancer
0
1
2
@JavleMilind reviews neoadj. GOLP in unresectable BTC. Does it hold up to NEO-GAP @FlavioRochaMD @rachnatshroff? Are we better off with TOPAZ-1/KEYNOTE-966? @curecc #BTC @TheLancetOncol
https://t.co/OTl8MHpoFP
0
6
12
🔥 Congratulations @rachnatshroff on receiving the WIMS Torchbearer Award 🌟 A nationally renowned leader in GI oncology, clinical trials, and mentorship, she continues to light the way for women in medicine and oncology @UAZHemeOnc @UAZCancer
3
3
19
Time away with your people (and a 🔥 DJ) is the best reset…
1
0
5